NCT01538589View on ClinicalTrials.gov

Special Survey for Patients With Type 1 or Type 2 Diabetes

CompletedOBSERVATIONAL

Enrollment

1,582

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DRUG

insulin aspart

Prescribed by the physicians as a result of normal clinical practice

Trial Locations (1)

1000005

Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT01538589 - Special Survey for Patients With Type 1 or Type 2 Diabetes | Biotech Hunter | Biotech Hunter